Cloud Platform Built on Microsoft Azure Delivers PAREXEL’s Valued Informatics Solutions on a Global, Trusted Architecture; Represents the First Offering of PAREXEL and Microsoft Alliance
BOSTON, December 12, 2017 — PAREXEL International Corporation, a leading global biopharmaceutical services organization, today introduced the Perceptive® Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.
Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s intelligent cloud services and investment in global compliance certifications and enterprise-grade security. The first group of integrated cloud services will include LIQUENT InSight®Regulatory Information Management (RIM), Study Start-Up, DataLabs® Electronic Data Capture (EDC), Managed Access Programs, and IMPACT ® Clinical Trial Management (CTMS).
“In drug development today, the time to treatment continues to grow longer. This is due, in large part, to the use of conventional, disparate systems that simply digitize manual processes,” said Paul Bidez, Vice President of Regulatory and Clinical Solutions for PAREXEL. “Perceptive Cloud represents an opportunity to automate and streamline workflows and provide greater access to high quality data, simplifying the drug development journey with the objective of ultimately bringing new therapies to patients sooner.”
Perceptive Cloud is designed to respond to the need within healthcare to deliver cost-effective innovation while trusting that sensitive information will stay secure across global environments. Introducing Perceptive Cloud represents the first milestone of the enterprise alliance between PAREXEL and Microsoft aimed at leveraging the cloud to optimize performance and jointly innovate to offer new clinical development solutions and more site- and patient-centric technologies.
“Most life sciences solutions to date have been developed with the end result in mind, not the user experience, creating bottlenecks and inefficiencies across the drug development chain,” said Paul Slater, Worldwide Industry Strategist, Pharmaceuticals, Microsoft Health. “Both Microsoft and PAREXEL are committed to developing technologies that better engage patients, sites and sponsors to optimize clinical and operational effectiveness and digitally transform health. The Perceptive Cloud is only the first step in this effort.”
PAREXEL Informatics delivers innovative technology solutions to help optimize patient engagement, clinical and regulatory processes, and provides analytics and visualization for PAREXEL’s Connected Journey™ of data-driven services. PAREXEL’s Connected Journey of technology, processes, and expertise supports clinical development and commercialization, with solutions to provide data-driven insights that enable our clients to make critical decisions more quickly. For more information on Perceptive Cloud, visit www.PAREXEL.com/Perceptive-Cloud.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.
Tel: +1 781 434 5104
Tel: +1 781 434 4772